Is our method of obtaining consent appropriate for randomised controlled trials in acute myocardial infarction?

New Zealand Medical Journal

Volumn 110, Issue 1049, 1997, Pages 298-299

  Williams, Barbara F ^a   French, John K ^a   White, Harvey D ^a  

^a GREEN LANE HOSPITAL   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BIOMEDICAL AND BEHAVIORAL RESEARCH; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; EMPIRICAL APPROACH; HEART INFARCTION; HUMAN; INFORMED CONSENT; RANDOMIZED CONTROLLED TRIAL;

BIOMEDICAL AND BEHAVIORAL RESEARCH; EMPIRICAL APPROACH;

HUMANS; INFORMED CONSENT; MYOCARDIAL INFARCTION; RANDOMIZED CONTROLLED TRIALS;

EID: 0031559415     PISSN: 00288446     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. White H, Aylward P, Frey M, et al. On behalf of the Hirulog Early Reperfusion/ Occlusion (HERO) Trial Investigators. A randomized, double-blind comparison of Hirulog versus heparin in patients receiving streptokinase and aspirin for acute myocardial infarction (HERO). Circulation, in press.
2. European Secondary Prevention Study Group. Translation of clinical trials into practice: a European population-based study of the use of thrombolysis for acute myocardial infarction. Lancet 1996; 347: 1203-7.
3. Jha P, Deoboer D, Sykora K, Naylor CD. Characteristics and mortality outcomes of thrombolysis trial participants and nonparticipants: a population based comparison. J Am Coll Cardiol 1996; 27: 1335-42.
4. White HD, Barbash GI, Califf RM, et al. Age and outcome with contemporary thrombolytic therapy. Results from the GUSTO-1 Trial. Circulation 1996; 94: 1826-33.
5. Ockene IS, Miner J, Shannon TA, Gore JM, Weiner BH, Ball SP. The consent process in the Thrombolysis in Myocardial Infarction (TIMI-phase 1) trial. Clin Res 1991; 39: 13-7.
6. Stiller CA. Centralised treatment, entry to trials and survival. Br J Cancer 1994; 70: 352-62.
7. Tobias JS, Souhami RL. Fully informed consent can be needlessly cruel. BMJ 1993; 307: 1199-201.
8. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI). Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1986; 1: 397-402.
9. ISIS-2 Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17 187 cases of suspected acute myocardial infarction: ISIS-2. Lancet 1988; 2: 349-60.
10. Collins R, Doll R, Peto R. Ethics of clinical trials. In: Williams CJ, ed. Introducing new treatments for cancer: practical ethical and legal problems. Chichester: Wiley 1992: p49-63.